Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome
and a common cause of liver cirrhosis and cancer. Akkermansia muciniphila (A. muciniphila) …

Chronic inflammatory diseases, such as rheumatoid arthritis, steatohepatitis, periodontitis,
chronic kidney disease, and others are associated with an increased risk of atherosclerotic …

Roseburia intestinalis is an anaerobic bacterium that produces butyric acid and belongs to
the phylum Firmicutes. There is increasing evidence that this bacterium has positive effects …

Background Maternal obesity is an important determinant of offspring obesity risk, which
may be mediated via changes in the infant microbiome. Objectives We examined infant …

The importance of gut-liver axis in the pathophysiology of metabolic dysfunction-associated
fatty liver disease (MAFLD) is being investigated more closely in recent times. However, the …

Abnormally high lymphocyte counts are seen in persons with nonalcoholic fatty liver disease
(NAFLD). Gut microbiota dysbiosis is a risk factor for NAFLD. We assessed the gut …

Gut microbiota plays an essential role in nonalcoholic fatty liver disease (NAFLD). However,
the contribution of individual bacterial strains and their metabolites to childhood NAFLD …

The physiopathology of liver diseases is complex and can be caused by various factors.
Bifidobacterium is a bacterial genus commonly found in the human gut microbiome and has …

Gut microbiota is known to have a significant impact on nonalcoholic fatty liver disease
(NAFLD), particularly in children with obesity. However, the specific functions of microbiota …

Background The specific microbiota and associated metabolites linked to non-alcoholic fatty
liver disease (NAFLD) are still controversial. Thus, we aimed to understand how the core gut …